Thu, Jul 10, 2014, 7:13 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

TaxuCardium Pharmaceuticals Group Inc. Message Board

  • globalthehappytrader globalthehappytrader Apr 11, 2013 12:46 PM Flag

    Excellagen and capital efficient Cardium

    Cardium Therapeutics, Inc. (CXM) Commercialization Status for Excellagen
    Cardium Therapeutics has a capital-efficient, asset-based business strategy focused on building a diversified portfolio of new and innovative bio-medical product opportunities and businesses, leveraging research and development investments by big pharma, venture, and institutional investors. A key component to that strategy is the company’s Excellagen advanced wound care management platform, which has already received FDA 510(k) clearance for U.S. marketing and sales.

    Principal commercialization factors:
    • Excellagen is the best-in-class acellular biological modulator designed to accelerate the growth of granulation tissue for wound healing.
    • Excellagen has FDA clearance for the treatment of a broad array of dermal wounds.
    • Excellagen is competitively positioned, offering an aseptically manufactured, pharmaceutically-formulated collagen in a flowable syringe-based format that is easy to use. !!!!! Is it??!!!!
    • Excellagen has multiple clinical studies backing up its unique effectiveness.
    • Selected as 2012 Top 10 Innovation in Podiatry by Podiatry Today magazine.
    • Excellagen outsourced supply chain is fully operational, including U.S. cold chain distributor: S Is it

    So where are the salesnumbers???

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CRXM
0.59-0.06(-8.89%)Jul 10 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.